Literature DB >> 15476872

Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.

Natalia Ilyushina1, Irina Rudneva, Alexandra Gambaryan, Nicolai Bovin, Nikolai Kaverin.   

Abstract

To determine the receptor binding properties of various H9 influenza virus escape mutants in the presence and absence of antibody, sialyloligosaccharides conjugated with biotinylated polyacrylamide were used. A mutant virus with a L226Q substitution showed an increased affinity for the Neu5Acalpha2-3Galbeta1-4Glc. Several escape mutants viruses carrying the mutation N193D bound to Neu5Acalpha2-6Galbeta1-4GlcNAc considerably stronger than to Neu5Acalpha2-6Galbeta1-4Glc. Several monoclonal antibodies unable to neutralize the escape mutants preserved the ability to bind to the hemagglutinin as revealed by enzyme-linked immunosorbent assay. In each case, the bound monoclonal antibodies did not prevent the binding of the mutant HA to high affinity substrates and did not displace them from the virus binding sites. Together, these data suggest that amino acid changes selected by antibody pressure may be involved in the specificity of host-cell recognition by H9 hemagglutinin and in the ability of viruses with these mutations to escape the neutralizing effect of antibodies in a differential way, depending on the specificity of the host cell receptor. It may be important in the natural evolution of the H9 subtype, a plausible candidate for the agent likely to cause a future pandemic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476872     DOI: 10.1016/j.virol.2004.08.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

Review 1.  H5N1 receptor specificity as a factor in pandemic risk.

Authors:  James C Paulson; Robert P de Vries
Journal:  Virus Res       Date:  2013-04-22       Impact factor: 3.303

2.  Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus.

Authors:  Barry Rockx; Eric Donaldson; Matthew Frieman; Timothy Sheahan; Davide Corti; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

3.  Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus.

Authors:  Erin M Sorrell; Hongquan Wan; Yonas Araya; Haichen Song; Daniel R Perez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

4.  Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity.

Authors:  Zhi-Yong Yang; Chih-Jen Wei; Wing-Pui Kong; Lan Wu; Ling Xu; David F Smith; Gary J Nabel
Journal:  Science       Date:  2007-08-10       Impact factor: 47.728

Review 5.  Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Authors:  Nicola Clementi; Elena Criscuolo; Matteo Castelli; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

6.  Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.

Authors:  L J Demma; T H Vanderford; J M Logsdon; M B Feinberg; S I Staprans
Journal:  Retrovirology       Date:  2006-03-20       Impact factor: 4.602

7.  The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.

Authors:  Nicolette Lee; Alexey M Khalenkov; Vladimir Y Lugovtsev; Derek D Ireland; Anastasia P Samsonova; Nicolai V Bovin; Raymond P Donnelly; Natalia A Ilyushina
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.